ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
5,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
5,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5,3,Headache,Headaches NEC,Headaches,Nerv,N
5,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
7,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
7,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
9,1,Skin depigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
10,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
10,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
12,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
12,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
13,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
13,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
14,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
15,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
16,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
17,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
18,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
18,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
19,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
19,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
19,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
20,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
20,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
21,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
22,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
23,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
24,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
26,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
27,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
27,2,Headache,Headaches NEC,Headaches,Nerv,N
27,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
27,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
28,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
28,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
28,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
29,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
30,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
31,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
32,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
33,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
34,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
35,2,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
35,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
36,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
37,1,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
38,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
38,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
39,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
40,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
40,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
41,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
41,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
42,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
43,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
43,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
43,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
44,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
45,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
45,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
46,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
47,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
48,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
49,1,Meningitis pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
49,2,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
49,3,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
50,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
50,2,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
50,3,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
51,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
52,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
53,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
53,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
53,3,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
53,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
54,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
55,1,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
56,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
56,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,1,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
58,1,Headache,Headaches NEC,Headaches,Nerv,N
58,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
58,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
59,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
59,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
60,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
61,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
61,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
62,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
64,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
65,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
66,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
66,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
66,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
66,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
67,1,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
68,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
69,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
70,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
70,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
71,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
72,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
72,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
72,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
74,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
74,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
75,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
75,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
75,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
75,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
76,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
76,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
78,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
79,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
80,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
80,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
81,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
81,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
82,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
83,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
84,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
84,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
85,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
85,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
85,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
85,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
85,5,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
86,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
87,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
87,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
88,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
88,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
88,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
89,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
90,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
91,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
91,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
91,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
92,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
93,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
93,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
94,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
95,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
96,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
96,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
97,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
97,2,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
98,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
98,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
98,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
99,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
100,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
100,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
102,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
103,2,Headache,Headaches NEC,Headaches,Nerv,N
104,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
104,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
105,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
106,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
106,2,Aphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
106,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
107,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
107,2,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
107,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
107,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
107,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
107,6,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
107,7,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
107,8,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
107,9,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
108,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
109,1,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
110,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
110,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
110,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
110,5,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
110,7,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
111,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
112,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
113,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
114,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
115,1,Headache,Headaches NEC,Headaches,Nerv,N
116,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
117,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
118,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
119,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
119,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
120,1,Headache,Headaches NEC,Headaches,Nerv,N
120,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
120,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
121,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
121,2,Headache,Headaches NEC,Headaches,Nerv,N
122,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
122,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
122,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
123,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
124,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
125,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
125,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
126,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
127,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
128,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
129,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
130,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
131,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
132,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
132,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
132,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
132,5,Headache,Headaches NEC,Headaches,Nerv,N
132,6,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
132,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,8,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
133,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
134,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
135,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
136,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
136,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
137,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
138,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
139,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
139,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
139,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
140,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
140,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
141,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
143,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
144,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
144,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
144,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
144,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
145,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
146,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
147,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
147,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
149,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
149,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
150,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
151,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
152,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
152,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
153,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
154,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
154,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
154,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
155,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
155,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
156,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
156,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
157,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
157,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
158,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
158,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
159,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
161,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
161,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
162,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
162,2,Headache,Headaches NEC,Headaches,Nerv,N
162,3,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
162,4,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
163,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
163,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
164,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
164,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
165,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
167,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
169,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
169,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
170,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
171,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
172,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
172,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
172,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,1,Parapsoriasis,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
173,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
173,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
174,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
174,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
176,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
176,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
176,3,Headache,Headaches NEC,Headaches,Nerv,N
177,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
177,2,Headache,Headaches NEC,Headaches,Nerv,N
177,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
177,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
177,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
178,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
179,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
179,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
179,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
179,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
180,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
180,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
180,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
181,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
181,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
182,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
183,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
183,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
184,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
184,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
184,3,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
184,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
184,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
185,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
185,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
186,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
186,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
186,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
187,1,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
188,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
188,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
188,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
189,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
189,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
189,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
189,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
189,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
189,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
190,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
190,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
190,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
190,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
191,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
191,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
191,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
191,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
191,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
192,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
193,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
194,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
196,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
197,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
198,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
199,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
200,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
200,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
201,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
201,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
202,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
202,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
202,3,Headache,Headaches NEC,Headaches,Nerv,N
202,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
202,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
202,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
202,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
203,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
203,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
203,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
204,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
204,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
205,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
205,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
206,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
206,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
208,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
208,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
209,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
210,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
211,1,Pregnancy on oral contraceptive,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
212,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
212,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
212,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
213,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
213,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
213,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
214,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
215,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
215,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
216,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
217,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
217,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
218,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
219,1,Headache,Headaches NEC,Headaches,Nerv,N
219,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
220,1,Huntington's disease,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
221,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
222,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
223,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
223,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
224,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
225,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
225,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
226,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
226,2,Headache,Headaches NEC,Headaches,Nerv,N
226,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
226,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
228,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
229,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
230,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
231,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
231,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
232,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
232,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
233,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
234,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
235,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
235,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
236,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
237,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
237,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
237,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
238,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
238,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
238,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
238,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
239,1,Angular cheilitis,Oral soft tissue infections,Oral soft tissue conditions,Gastr,N
239,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
240,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
240,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
240,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
241,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
241,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
242,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
242,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
243,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
244,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
245,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
245,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
245,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
245,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
246,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
247,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
248,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
249,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
250,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
251,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
251,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
252,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
253,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
253,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
254,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
254,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
254,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
255,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
256,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
257,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
257,2,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
258,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
258,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
258,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
259,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
260,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
260,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
260,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
260,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
260,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
261,1,Drowning,Death and sudden death,Fatal outcomes,Genrl,Y
262,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
263,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
263,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
265,1,Dermatitis artefacta,Skin injuries NEC,Injuries NEC,Inj&P,N
265,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
265,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
265,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
265,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
266,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
267,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
268,1,Headache,Headaches NEC,Headaches,Nerv,N
268,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
269,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
270,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
271,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
272,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
273,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
273,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
274,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
275,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
275,2,Ear malformation,Ear disorders congenital NEC,Ear and labyrinthine disorders congenital,Cong,N
275,3,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
275,4,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
275,5,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
275,6,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
276,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
277,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
278,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
278,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
278,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
278,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
279,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
279,2,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
280,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
280,2,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
281,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
281,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
281,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
281,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
281,5,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
281,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
282,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
282,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
282,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
283,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
284,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
285,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
286,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
286,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
287,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
288,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
288,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
288,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
289,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
290,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
290,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
290,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
291,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
293,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
294,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
295,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
296,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
296,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
296,3,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
297,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
298,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
298,2,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
299,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
300,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
301,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
302,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
303,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
304,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
305,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
305,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
306,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
307,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
307,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
307,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
308,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
308,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
309,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
309,2,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
309,3,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
310,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
311,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
312,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
313,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
314,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
315,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
316,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
317,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
318,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
319,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
320,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
321,1,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
322,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
322,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
323,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
324,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
324,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
324,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
324,5,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
325,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
326,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
327,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,2,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
328,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
329,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
330,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
331,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
332,1,Balanoposthitis,Penile and scrotal infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
332,2,Urine analysis abnormal,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
333,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
334,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
334,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
334,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
335,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
336,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
337,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
338,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
339,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
340,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
340,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
340,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
341,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
342,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
343,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
343,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
344,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
345,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
346,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
346,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
347,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
349,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
350,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
351,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
352,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
352,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
353,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
353,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
353,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
353,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
354,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
354,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
355,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
356,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
357,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
357,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
358,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
358,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
358,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
359,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
360,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
361,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
362,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
363,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
363,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
364,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
365,1,Potter's syndrome,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,Y
366,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
367,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
367,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
367,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
368,1,Intermittent claudication,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
369,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
370,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
370,2,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
371,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
371,2,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
371,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
371,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
372,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
372,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
373,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
374,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
375,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
376,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
377,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
378,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
378,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
379,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
380,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
380,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
380,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
380,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
381,1,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
382,1,Gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
383,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
384,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
385,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
386,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
387,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
387,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
387,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
388,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
388,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
388,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
389,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
390,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
390,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
391,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
391,2,Headache,Headaches NEC,Headaches,Nerv,N
391,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
391,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
391,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
392,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
393,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
394,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
394,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
395,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
395,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
395,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
395,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
396,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
396,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
397,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
398,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
399,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
400,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
400,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
400,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
401,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
401,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
401,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
401,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
402,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
402,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
403,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
403,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
404,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
404,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
405,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
405,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
405,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
406,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
407,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
407,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
407,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
407,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
407,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
407,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
408,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
408,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
409,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
409,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
410,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
410,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
411,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
411,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
411,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
411,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
411,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
411,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
411,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
412,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
412,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
412,3,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
413,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
413,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
414,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
415,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
415,2,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
416,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
417,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
418,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
418,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
419,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
419,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
419,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
420,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
421,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
422,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
422,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
423,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
423,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
424,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
424,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
424,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
425,1,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
425,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
426,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
427,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
427,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
428,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
428,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
428,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
429,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
430,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
431,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
432,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
433,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
433,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
434,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
435,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
436,1,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
437,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
437,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
438,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
439,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
440,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
440,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
441,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
441,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
441,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
441,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
441,5,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
441,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
441,7,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
442,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
443,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
443,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
444,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
444,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
444,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
444,4,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
444,5,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
444,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
445,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
446,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
446,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
447,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
447,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
448,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
449,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
450,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
451,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
452,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
452,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
453,1,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
454,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
455,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
456,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
457,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
458,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
459,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
460,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
461,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
461,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
462,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
462,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
463,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
464,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
465,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
466,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
466,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
466,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
467,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
468,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
469,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
470,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
471,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
471,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
472,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
473,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
474,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
475,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
475,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
476,1,Headache,Headaches NEC,Headaches,Nerv,N
477,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
478,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
479,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
480,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
481,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
482,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
483,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
484,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
485,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
485,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
485,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
486,1,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
487,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
488,1,Headache,Headaches NEC,Headaches,Nerv,N
489,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
490,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
490,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
491,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
491,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
491,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
491,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
491,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
492,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
492,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
494,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
495,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
496,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
496,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
497,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
498,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
498,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
498,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
498,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
499,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
499,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
500,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
500,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
501,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
501,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
502,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
502,2,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
503,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
504,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
505,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
506,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
507,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
508,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
509,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
509,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
509,3,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
510,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
510,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
511,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
512,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
512,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
512,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
512,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
512,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
512,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
513,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
514,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
515,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
516,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
516,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
517,1,Headache,Headaches NEC,Headaches,Nerv,N
518,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
519,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
519,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
520,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
521,1,Headache,Headaches NEC,Headaches,Nerv,N
521,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
522,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
523,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
523,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
524,1,Headache,Headaches NEC,Headaches,Nerv,N
524,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
525,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
526,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
527,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
528,1,Headache,Headaches NEC,Headaches,Nerv,N
529,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
530,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
530,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
530,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
531,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
531,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
532,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
532,2,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
533,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
534,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
534,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
535,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
535,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
535,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
536,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
536,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
537,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
537,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
537,3,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
538,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
538,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
540,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
541,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
542,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
542,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
542,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
543,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
544,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
545,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
546,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
547,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
547,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
548,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
548,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
548,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
549,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
549,2,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
549,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
550,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
551,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
552,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
552,2,Headache,Headaches NEC,Headaches,Nerv,N
553,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
553,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
554,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
555,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
556,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
556,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
556,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
557,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
558,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
559,1,Headache,Headaches NEC,Headaches,Nerv,N
559,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
560,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
561,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
562,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
562,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
563,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
563,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
563,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
563,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
564,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
564,2,Ketonuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
564,3,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
564,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
565,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
566,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
566,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
566,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
567,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
568,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
569,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
570,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
570,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
571,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
572,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
573,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
573,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
574,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
574,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
574,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
574,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
575,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
575,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
576,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
576,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
577,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
578,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
578,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
579,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
579,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
580,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
581,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
582,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
582,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
582,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
582,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
583,1,Headache,Headaches NEC,Headaches,Nerv,N
583,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
584,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
584,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
585,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
586,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
587,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
588,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
588,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
589,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
590,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
591,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
592,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
593,1,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
594,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
595,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
596,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
596,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
596,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
596,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
596,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
596,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
597,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
598,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
599,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
599,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
599,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
599,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
600,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
601,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
602,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
603,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
604,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
605,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
606,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
606,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
606,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
606,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
607,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
607,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
607,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
608,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
609,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
609,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
609,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
609,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
610,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
611,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
612,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
613,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
614,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
614,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
614,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
614,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
614,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
615,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
616,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
616,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
616,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
616,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
617,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
618,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
619,1,Headache,Headaches NEC,Headaches,Nerv,N
620,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
620,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,3,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
621,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
621,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
622,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
622,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
623,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
624,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
624,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
625,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
625,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
626,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
626,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
627,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
627,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
628,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
629,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
630,1,Oesophageal spasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
630,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
631,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
632,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
633,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
634,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
635,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
635,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
636,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
636,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
637,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
637,2,Headache,Headaches NEC,Headaches,Nerv,N
637,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
638,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
639,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
640,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
640,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
640,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
640,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
640,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
640,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
640,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
642,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
643,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
643,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
644,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
645,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
646,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
647,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
647,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
648,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
648,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
649,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
650,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
651,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
651,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
651,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
652,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
652,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
652,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
653,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
653,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
653,3,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
654,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
654,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
654,3,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,4,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
654,5,Coma,Coma states,Neurological disorders NEC,Nerv,N
654,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
655,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
655,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
656,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
656,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
657,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
658,1,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
659,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
659,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
660,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
661,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
661,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
662,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
663,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
664,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
664,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
664,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
665,1,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
665,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
666,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
666,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
667,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
668,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
668,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
669,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
670,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
671,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
671,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
672,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
673,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
674,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
675,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
676,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
676,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
677,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
677,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
678,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
678,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
679,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
679,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
680,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
680,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
680,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
681,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
682,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
682,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
682,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
682,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
683,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
684,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
685,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
685,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
686,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
687,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
687,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
688,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
688,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
688,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
688,4,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
689,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
690,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
691,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
692,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
692,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
693,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
693,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
693,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
694,1,Holmes-Adie pupil,Pupil disorders,Ocular neuromuscular disorders,Eye,N
695,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
696,1,Cerebral artery occlusion,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
696,2,Headache,Headaches NEC,Headaches,Nerv,N
697,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
697,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
698,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
698,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
698,3,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
699,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
699,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
700,1,Acne,Acnes,Skin appendage conditions,Skin,N
700,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
701,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
702,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
703,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
704,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
704,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
704,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
705,1,Biliary colic,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
706,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
706,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
706,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
706,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
707,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
708,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
709,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
709,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
709,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
709,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
710,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
710,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
711,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
711,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
711,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
711,4,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
712,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
713,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
714,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
714,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
715,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
716,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
717,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
717,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
718,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
719,1,Headache,Headaches NEC,Headaches,Nerv,N
720,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
720,2,Breast pain,Breast signs and symptoms,Breast disorders,Repro,N
720,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
721,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
722,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
722,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
723,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
724,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
725,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
725,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
725,3,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
725,4,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
726,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
727,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
727,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
728,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
728,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
728,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
729,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
730,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
730,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
730,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
731,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
732,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
732,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
733,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
733,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
734,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
734,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
734,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
735,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
735,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
736,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
737,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
738,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
739,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
740,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
740,2,Headache,Headaches NEC,Headaches,Nerv,N
740,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
741,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
742,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
743,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
744,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
745,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
745,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
745,3,Headache,Headaches NEC,Headaches,Nerv,N
745,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
746,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
747,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
748,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
749,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
750,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
750,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
750,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
750,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
750,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
750,6,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
750,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
750,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
750,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
751,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
751,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
752,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
753,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
753,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
754,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
754,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
755,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
756,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
757,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
758,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
758,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
758,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
759,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
759,2,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
759,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
759,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
759,5,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
759,6,Flight of ideas,Thinking disturbances,Disturbances in thinking and perception,Psych,N
759,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
759,8,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
759,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
759,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
759,11,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
760,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
760,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
761,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
762,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
764,1,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
765,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
765,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
765,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
766,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
767,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
768,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
768,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
769,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
769,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
769,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
769,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
771,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
771,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
771,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
771,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
772,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
772,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
773,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
773,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
773,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
773,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
773,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
773,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
774,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
774,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
774,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
774,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
774,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
774,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
774,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
774,8,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
774,9,Headache,Headaches NEC,Headaches,Nerv,N
774,10,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
774,11,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
774,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
774,13,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
774,14,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
774,15,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
774,16,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
775,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
776,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
777,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
777,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
778,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
778,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
779,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
780,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
781,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
781,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
781,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
782,1,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
783,1,Leukoplakia oral,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
784,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
784,2,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
785,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
785,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
785,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
785,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
786,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
786,2,Headache,Headaches NEC,Headaches,Nerv,N
786,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
786,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
786,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
787,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
789,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
790,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
791,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
791,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
792,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
793,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
793,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
794,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
795,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
795,2,Headache,Headaches NEC,Headaches,Nerv,N
796,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
797,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
798,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
799,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
800,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
801,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
802,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
803,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
804,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
804,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
805,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
805,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
806,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
807,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
808,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
809,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
810,1,Seborrhoeic dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
811,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
811,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
811,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
811,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
811,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
812,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
812,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
812,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
813,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
813,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
814,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
815,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
816,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
817,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
818,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
818,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
819,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
820,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
821,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
821,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
822,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
823,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
824,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
825,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
826,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
827,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
827,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
828,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
829,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
829,2,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
829,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
829,4,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
829,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
830,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
831,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
831,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
831,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
831,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
832,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
832,2,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
832,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
832,4,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
832,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
833,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
834,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
835,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
835,2,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
835,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
836,1,Chemical poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
836,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
836,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
836,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
837,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
837,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
837,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
838,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
838,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
839,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
840,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
841,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
841,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
842,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
842,2,Headache,Headaches NEC,Headaches,Nerv,N
842,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
842,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
842,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
843,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
843,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
844,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
844,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
845,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
846,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
846,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
847,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
848,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
848,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
849,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
849,2,Headache,Headaches NEC,Headaches,Nerv,N
849,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
849,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
849,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
849,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
850,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
851,1,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
852,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
853,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
854,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
855,1,Breast enlargement,Breast disorders NEC,Breast disorders,Repro,N
855,2,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
856,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
856,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
857,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
858,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
858,2,Headache,Headaches NEC,Headaches,Nerv,N
858,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
858,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
858,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
859,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
859,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
859,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
860,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
861,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
862,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
862,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
862,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
863,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
863,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
864,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
865,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
866,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
866,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
866,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
866,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
866,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
866,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
867,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
867,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
868,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
869,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
869,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
870,1,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
871,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
871,2,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
872,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
872,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
872,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
872,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
872,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
872,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
872,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
872,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
872,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
873,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
874,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
874,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
874,3,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
874,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
875,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
876,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
877,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
877,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
878,1,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
878,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
879,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
879,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
879,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
879,4,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
879,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
880,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
880,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
880,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
881,1,Headache,Headaches NEC,Headaches,Nerv,N
882,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
882,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
883,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
883,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
883,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
885,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
886,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
887,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
887,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
887,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
888,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
889,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
889,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
890,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
891,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
891,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
891,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
892,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
893,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
893,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
893,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
893,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
894,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
895,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
895,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
896,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
897,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
897,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
898,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
899,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
899,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
899,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
899,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
900,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
900,2,Headache,Headaches NEC,Headaches,Nerv,N
900,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
900,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
900,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
901,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
902,1,Headache,Headaches NEC,Headaches,Nerv,N
903,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
903,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
904,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
904,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
904,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
905,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
905,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
906,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
906,2,Headache,Headaches NEC,Headaches,Nerv,N
906,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
906,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
907,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
907,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
907,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
908,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
909,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
909,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
910,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
911,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
911,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
911,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
911,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
912,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
913,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
913,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
914,1,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
915,1,Epileptic aura,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
916,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
916,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
916,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
916,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
917,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
917,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
918,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
918,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
918,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
918,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
918,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
918,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
918,7,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
918,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
919,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
919,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
919,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
919,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
919,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
919,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
920,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
920,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
920,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
921,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
921,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
921,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
921,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
921,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
921,6,Headache,Headaches NEC,Headaches,Nerv,N
921,7,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
921,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
921,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
921,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
921,11,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
921,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
921,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
922,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
923,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
924,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
925,1,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
926,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
926,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
927,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
928,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
928,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
929,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
930,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
930,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
931,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
932,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
933,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
934,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
935,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
936,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
936,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
937,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
938,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
939,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
940,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
940,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
941,1,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
942,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
942,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
942,3,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
942,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
942,5,Migraine,Migraine headaches,Headaches,Nerv,N
943,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
943,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
944,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
944,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
944,3,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
944,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
945,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
946,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
946,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
947,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
947,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
948,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
948,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
948,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
948,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
949,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
950,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
951,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
952,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
953,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
954,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
954,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
955,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
956,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
957,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
958,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
958,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
958,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
959,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
959,2,Headache,Headaches NEC,Headaches,Nerv,N
959,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
960,1,Headache,Headaches NEC,Headaches,Nerv,N
960,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
960,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
960,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
960,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
961,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
961,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
961,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
961,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
961,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
961,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
962,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
962,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
962,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
962,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
962,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
963,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
964,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
964,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
965,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
966,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
967,1,Headache,Headaches NEC,Headaches,Nerv,N
967,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
967,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
968,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
969,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
970,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
970,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
971,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
971,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
971,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
972,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
972,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
972,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
973,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
973,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
973,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
973,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
973,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
974,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
975,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
975,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
976,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
976,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
977,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
978,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
978,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
978,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
979,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
979,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
980,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
981,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
981,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
981,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
981,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
981,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
982,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
982,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
982,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
983,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
983,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
984,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
984,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
984,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
984,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
984,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
985,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
985,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
986,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
986,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
987,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
988,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
989,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
990,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
990,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
991,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
991,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
991,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
991,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
991,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
992,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
992,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
993,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
994,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
994,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
994,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
995,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
995,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
996,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
996,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
996,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
996,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
996,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
997,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
998,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
998,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
999,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1000,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1001,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1001,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1002,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1003,1,Headache,Headaches NEC,Headaches,Nerv,N
1003,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1003,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1003,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1004,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1005,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1005,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1005,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1005,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1005,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1005,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1006,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
1006,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1006,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1007,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1007,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1008,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1009,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1010,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1011,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1011,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1011,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1012,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1012,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1012,3,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1013,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1014,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1014,2,Unintended pregnancy,Unintended pregnancies,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1015,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1015,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1016,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1016,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1016,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1016,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1017,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1018,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1018,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1018,3,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1019,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1020,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1020,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1021,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1021,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1022,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1023,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1023,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1024,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1025,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1025,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1026,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1027,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1027,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1027,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1027,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1027,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1027,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1028,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1028,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1029,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1029,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
1030,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1031,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1031,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1031,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1032,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1032,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1032,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1032,4,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1033,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1033,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1033,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1033,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1033,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1033,6,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1033,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1033,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1033,9,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1033,10,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1033,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1033,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1034,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
1034,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1034,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1035,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1036,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1037,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1037,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1037,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1037,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1037,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1038,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1038,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1038,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1039,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1040,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1040,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1040,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1041,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1041,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1041,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1041,4,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
1041,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1042,1,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1042,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1042,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1042,4,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1042,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1042,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1043,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1043,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1044,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1044,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1045,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1045,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1046,1,Gingivitis ulcerative,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1047,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1047,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1047,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1047,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1048,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1048,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1048,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1049,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1049,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1050,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1050,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1050,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1050,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1051,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1052,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1053,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1053,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1054,1,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1054,2,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1054,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1054,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1055,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1055,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1055,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1056,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1056,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1056,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1056,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1056,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1056,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1057,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1057,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1057,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1057,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1058,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1058,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1058,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1059,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1059,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1059,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1060,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1060,2,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1061,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1061,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1061,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1062,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1063,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1063,2,Pelvic inflammatory disease,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1064,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1065,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1065,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1066,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1067,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
1067,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1067,3,Sleep paralysis,Abnormal sleep-related events,Sleep disturbances (incl subtypes),Nerv,N
1068,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1068,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1068,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1069,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1069,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1070,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1071,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1072,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1072,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1072,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1072,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1072,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1073,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1073,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1073,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1074,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1075,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1076,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1076,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1077,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1077,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1077,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1078,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1078,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1078,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1078,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1079,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1079,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1079,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1080,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1081,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1081,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1081,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1081,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1082,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1082,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1083,1,Antipsychotic drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1083,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1083,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1083,4,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1083,5,Flight of ideas,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1083,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1083,7,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1083,8,Persecutory delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1083,9,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1084,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1084,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1084,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1085,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1085,2,Proctitis,Rectal inflammations NEC,Gastrointestinal inflammatory conditions,Gastr,N
1085,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1086,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1086,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1086,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1086,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1086,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1086,6,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1086,7,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1086,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1087,1,Gingival blister,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1087,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1088,1,Ophthalmic migraine,Migraine headaches,Headaches,Nerv,N
1089,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1089,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1089,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1089,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1089,5,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1090,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1091,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1092,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1092,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1093,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1093,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1093,3,Headache,Headaches NEC,Headaches,Nerv,N
1093,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1093,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1093,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1094,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1094,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1095,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1095,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1095,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1095,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1096,1,Cerebral vasoconstriction,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1096,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1097,1,Cerebral vasoconstriction,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1098,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1098,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1098,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1099,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1100,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1101,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1102,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1103,1,Cerebellar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1104,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1105,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1106,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1107,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1107,2,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1108,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1108,2,Inappropriate affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
1109,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1109,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1110,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1111,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1112,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1113,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1113,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1113,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1113,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1113,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1113,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1113,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1113,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1113,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1113,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1113,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1113,12,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1114,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1114,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1114,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1114,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1115,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1115,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1116,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1117,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1118,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1118,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1118,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1118,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1118,5,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
1118,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1118,7,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1120,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1121,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1121,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1122,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1122,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1123,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1123,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1123,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1124,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1125,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1126,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1126,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1126,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1126,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1126,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1127,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1127,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1127,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1128,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1128,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1129,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1129,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1130,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1131,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1131,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1131,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1131,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1131,5,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1131,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1131,7,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1131,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1132,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1132,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1132,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1133,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
1134,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1135,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1135,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1136,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1136,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1136,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1136,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1136,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1137,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1138,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1139,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1139,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1139,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1139,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1139,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1139,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1139,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1140,1,Dilatation atrial,Myocardial disorders NEC,Myocardial disorders,Card,N
1140,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1140,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1140,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1140,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1141,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1142,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1143,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1143,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1143,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1143,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1143,5,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1143,6,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1143,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1143,8,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1143,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1143,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1143,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1144,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1144,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1144,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1144,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1144,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1144,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1145,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1145,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1145,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1145,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1145,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1145,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1146,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1147,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1148,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1148,2,Headache,Headaches NEC,Headaches,Nerv,N
1148,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1148,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1149,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1149,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1149,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1150,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1150,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1151,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1152,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1152,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1153,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1153,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1153,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1154,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1155,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1155,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1155,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1155,6,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1155,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1155,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1156,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1156,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1156,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1156,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1157,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1157,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1158,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1158,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1158,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1158,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1158,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1158,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1158,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1159,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1159,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1159,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1159,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1159,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1160,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1161,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1161,2,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
1161,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1162,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1162,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1163,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1164,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1165,1,Blood carbon monoxide abnormal,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1166,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1166,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1166,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1167,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1167,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1168,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1168,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1168,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1169,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1169,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1169,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1169,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1170,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1171,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1171,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1171,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1171,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1171,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1171,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1171,7,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1171,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1171,9,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1171,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1171,11,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1171,12,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1172,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1173,1,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1174,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1174,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1174,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1175,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1176,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1176,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1176,3,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
1177,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1177,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1178,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1178,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1178,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1179,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1180,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1180,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1181,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1182,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1182,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1182,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1183,1,Cataplexy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1183,2,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1183,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1183,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1183,5,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1183,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1184,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1184,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1185,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1186,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1186,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1187,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1188,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1188,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1189,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1189,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1190,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1190,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1190,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1191,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1192,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1192,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1193,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1194,1,Headache,Headaches NEC,Headaches,Nerv,N
1194,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1194,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1195,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1195,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1195,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1195,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1195,5,Headache,Headaches NEC,Headaches,Nerv,N
1195,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1196,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1197,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1197,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1197,3,Headache,Headaches NEC,Headaches,Nerv,N
1197,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1197,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1198,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1199,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1199,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1200,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1201,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1201,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1202,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1203,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1203,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1203,3,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
1203,4,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1203,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1203,6,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1203,7,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1203,8,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
1204,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1204,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1205,1,Cardiospasm,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1205,2,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1206,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1206,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1206,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1207,1,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1207,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1207,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1207,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1207,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1207,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1207,7,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1207,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1208,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1209,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1209,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1209,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1209,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1209,5,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1210,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1211,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1211,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1211,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1212,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1213,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
1213,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1214,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1214,3,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
1214,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1214,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1214,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1214,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1214,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1214,9,Rest regimen,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1214,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1215,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1215,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1216,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1217,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1217,2,Duodenogastric reflux,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1218,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1218,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1218,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1218,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1218,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1219,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1219,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1219,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1219,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1219,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1219,6,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1219,7,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1220,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1220,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1220,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1221,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1221,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1222,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
1222,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1222,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1222,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1222,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1222,6,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1223,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1223,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1223,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1223,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1223,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1223,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1223,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1223,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1223,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1224,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1224,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1225,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1225,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1225,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1225,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1226,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1226,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
1226,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1226,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1226,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1226,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1226,7,Sialoadenitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1226,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1226,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1226,10,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1227,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1227,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1228,1,Blood carbon monoxide increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
1228,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1228,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1228,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1228,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1228,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1228,7,Headache,Headaches NEC,Headaches,Nerv,N
1228,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1228,9,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1228,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1228,11,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1229,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1229,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1229,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1229,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1230,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1230,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1230,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1231,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1231,2,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
1231,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1231,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1232,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1232,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1232,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1232,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1233,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1233,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1234,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1235,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1235,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1236,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1237,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1237,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1237,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1237,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1237,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1238,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1238,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1238,3,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1238,4,Gingival ulceration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1238,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1238,6,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1239,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1239,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1239,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1239,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1239,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1239,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1239,7,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1239,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1239,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1239,10,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1239,11,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1239,12,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
1240,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1241,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1241,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1242,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1242,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1242,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1242,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1242,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1243,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1243,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1243,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1243,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1243,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1243,6,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1243,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1243,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1243,9,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1244,1,Mucosa vesicle,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1245,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1245,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1246,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1247,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1247,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1247,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1247,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1247,5,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1248,1,Breast feeding,Pregnancy related circumstances,Gender related factors,SocCi,N
1248,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1248,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1249,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1250,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1250,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1250,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1250,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1250,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1251,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1251,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1251,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1252,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1252,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1252,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1252,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1252,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1252,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1252,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1252,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1253,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1254,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
1254,2,Human papilloma virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1254,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1254,4,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
1254,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1254,6,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1254,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1255,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1256,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1256,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1256,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1257,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1258,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1258,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1259,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1259,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1260,1,Headache,Headaches NEC,Headaches,Nerv,N
1260,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1260,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1261,1,Application site oedema,Application site reactions,Administration site reactions,Genrl,N
1261,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1261,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1262,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1262,2,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1262,3,Application site scab,Application site reactions,Administration site reactions,Genrl,N
1262,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1263,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1264,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1264,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1265,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1265,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1265,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1266,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1266,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1267,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1267,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1268,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1269,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1269,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1269,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1269,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1269,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1269,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1270,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1271,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1271,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1271,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1271,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1271,5,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1272,1,Migraine,Migraine headaches,Headaches,Nerv,N
1272,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1272,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1272,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1273,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1273,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1273,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1273,4,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1273,5,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1273,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1273,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1273,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1274,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1274,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1274,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1274,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1275,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1275,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1276,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1276,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1277,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1277,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1278,1,Headache,Headaches NEC,Headaches,Nerv,N
1278,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1279,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1280,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1280,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1280,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1280,4,Headache,Headaches NEC,Headaches,Nerv,N
1280,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1281,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1282,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1283,1,Squamous cell carcinoma of the oral cavity,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1284,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1284,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1284,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1284,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1285,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1286,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1286,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1288,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1288,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1288,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1288,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1288,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1289,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1289,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1290,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1290,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1291,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1291,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1291,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1291,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1292,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1293,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1293,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1293,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1293,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1293,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1293,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1294,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1294,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1295,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1295,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1296,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1296,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1297,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1297,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1297,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1298,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1298,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1299,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1300,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1300,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1301,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1302,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1302,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1302,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1303,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1303,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1303,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1303,4,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1303,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1304,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1305,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1306,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1306,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1306,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1306,4,Application site scar,Application site reactions,Administration site reactions,Genrl,N
1306,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1306,6,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1306,7,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1307,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1307,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1307,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1308,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1309,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1309,2,Dental implantation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1309,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1309,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1309,5,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1309,6,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1309,7,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1309,8,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1309,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1309,10,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1309,11,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1310,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1310,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1311,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1311,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1312,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1313,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1313,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1313,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1313,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1313,5,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1313,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1313,7,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1313,8,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1314,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1314,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1314,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1315,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1315,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1315,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
1315,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1315,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1315,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1316,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1316,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1317,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1317,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1318,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1318,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1318,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1319,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1320,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1320,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1320,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1321,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1322,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1322,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1323,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1323,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1323,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1324,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1324,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1325,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
1326,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1326,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1327,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1328,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1328,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1328,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1328,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1329,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1330,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1331,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1331,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1332,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1332,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1332,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1332,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1333,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1334,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1334,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1334,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1335,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1335,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1336,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1336,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1337,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1337,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1337,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1337,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1338,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1339,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1339,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1339,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1339,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1339,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1340,1,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
1340,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1341,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1341,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1342,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1342,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1343,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1343,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1343,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1344,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1344,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1344,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1345,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1346,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1346,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1346,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1346,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1346,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1346,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1346,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1347,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1347,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1347,3,Blood phosphorus increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1347,4,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1347,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1347,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1347,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1347,8,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1347,9,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1348,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1348,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1348,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1349,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1349,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1349,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1350,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1350,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1351,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1351,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1351,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1352,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1352,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1353,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1353,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1354,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1354,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1354,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1355,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1355,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1356,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1356,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1356,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1357,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1357,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1358,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1358,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1358,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1358,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1358,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1359,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1359,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1360,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1361,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1361,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1361,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1361,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1362,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1363,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1363,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1363,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1364,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1364,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1365,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1365,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1365,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1365,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1366,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1366,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1367,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1367,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1368,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1368,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1368,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1368,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1368,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1368,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1368,7,Disability,Disability issues,Lifestyle issues,SocCi,N
1368,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1368,9,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1368,10,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1368,11,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1368,12,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1368,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1368,14,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1368,15,Headache,Headaches NEC,Headaches,Nerv,N
1368,16,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1368,17,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1368,18,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1368,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1368,20,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1368,21,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1369,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1369,2,Headache,Headaches NEC,Headaches,Nerv,N
1370,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1370,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1370,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1370,4,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
1371,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1371,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1372,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1373,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1374,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1374,2,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1374,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1375,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1375,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1376,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1376,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1376,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1377,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1377,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1377,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1378,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1379,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1379,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1380,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1380,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1380,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1381,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1382,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1382,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1382,3,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1382,4,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1382,5,Henoch-Schonlein purpura nephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1382,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1382,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1382,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1383,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1383,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1383,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1383,4,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1383,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1383,6,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1383,7,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1383,8,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1383,9,Sjogren's syndrome,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1384,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1385,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1386,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1386,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1386,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1386,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1387,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1387,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1388,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1388,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1388,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1388,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1389,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1389,2,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1390,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1390,2,Headache,Headaches NEC,Headaches,Nerv,N
1390,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1391,1,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1391,2,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
1392,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1392,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1393,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1393,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1394,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1395,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1396,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1396,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1397,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1397,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1398,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1399,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1399,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1399,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1400,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1400,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1401,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1402,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1402,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1402,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1403,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1403,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1404,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1405,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1405,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1405,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1405,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1405,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1406,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1406,2,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1406,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1407,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1408,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1408,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1409,1,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
1410,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1410,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1411,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1411,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1412,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1412,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1412,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1413,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1413,2,Somnambulism,Parasomnias,Sleep disorders and disturbances,Psych,N
1414,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1414,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1415,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1416,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1416,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1417,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1417,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1417,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1418,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1418,2,Hyperaemia,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1418,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1418,4,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1418,5,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1419,1,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1420,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1421,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1421,2,Ventricular failure,Heart failures NEC,Heart failures,Card,N
1422,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1422,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1422,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1422,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1422,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1422,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1423,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1423,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1423,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1423,4,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1424,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
1424,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1425,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1426,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1427,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1427,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1427,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1427,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1427,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1428,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1428,2,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1428,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1428,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1428,5,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1429,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1430,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1431,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1431,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1432,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1432,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1432,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1433,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1433,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1433,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1434,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1434,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1434,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1435,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1435,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1436,1,Blood urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1436,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1437,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1437,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1437,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1438,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1438,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1438,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1439,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1439,2,Nasal disorder,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1440,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1440,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1441,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1442,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1443,1,Polydactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1444,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1445,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1446,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1446,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1447,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1447,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1447,3,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1447,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1447,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1447,6,Headache,Headaches NEC,Headaches,Nerv,N
1448,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1449,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1449,2,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1450,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1450,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1450,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1450,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1451,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1451,2,Drug chemical incompatibility,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1451,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1452,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1452,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1452,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1453,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1453,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1454,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1454,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1454,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1455,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1455,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1455,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1455,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1455,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1455,6,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1456,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1456,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1456,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1457,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1457,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1457,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1457,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1458,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1459,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1460,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1460,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1460,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1460,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1460,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1460,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1461,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1461,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1461,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1461,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1461,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1461,6,Lacrimal disorder,Lacrimation disorders,Eye disorders NEC,Eye,N
1461,7,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1461,8,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
1462,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1462,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1463,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1464,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1464,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1464,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1464,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1465,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
1465,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1465,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1465,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1465,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1465,6,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1466,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1466,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1466,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1467,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1467,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1467,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1467,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1467,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1468,1,Aura,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1468,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1468,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1468,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1468,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1469,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1469,2,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1469,3,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1469,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1469,5,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1469,6,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1469,7,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1469,8,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1469,9,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1469,10,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1470,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1470,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1470,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1470,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1471,1,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1471,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1471,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1471,4,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1472,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1472,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1472,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1473,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1473,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1474,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1475,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1476,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1477,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1477,2,Headache,Headaches NEC,Headaches,Nerv,N
1477,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1477,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1478,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1478,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1478,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1479,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1479,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1479,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1479,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1480,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1480,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1481,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1481,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1482,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1482,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1482,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1482,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1483,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1483,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1483,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1483,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1483,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1483,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1483,7,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1484,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1484,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1485,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1486,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1486,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1487,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1487,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1488,1,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1489,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1489,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1490,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
1490,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1491,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1491,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1491,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1491,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1492,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1492,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1492,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1492,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1492,5,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1493,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1494,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1495,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1496,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1496,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1497,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1497,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1498,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1499,1,Penile ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1500,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1500,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1501,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1502,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1503,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1503,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
1504,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1505,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1505,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1506,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1507,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1507,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1507,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1507,4,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1507,5,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1507,6,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1508,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1508,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1508,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1508,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1509,1,Headache,Headaches NEC,Headaches,Nerv,N
1509,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1509,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1510,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1510,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1510,3,Headache,Headaches NEC,Headaches,Nerv,N
1510,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1510,5,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1510,6,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1511,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
1512,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1512,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1513,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1513,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1514,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1514,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1514,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1514,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1514,5,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1514,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1514,7,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1515,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1515,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1515,3,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1515,4,Vulvovaginal pain,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1516,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1516,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1516,3,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1517,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1517,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1518,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1518,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
1518,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1518,4,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1519,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1519,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1520,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1521,1,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1521,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1522,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1522,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1523,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1523,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1524,1,Headache,Headaches NEC,Headaches,Nerv,N
1524,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1524,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1525,1,Headache,Headaches NEC,Headaches,Nerv,N
1525,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1526,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1526,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1527,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1527,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1528,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1529,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1529,2,Blood pressure measurement,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1529,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1529,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1529,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1529,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1529,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1529,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1529,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1529,10,Reaction to sweetener,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1529,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1530,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1531,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1532,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1532,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1532,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1533,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1533,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1533,3,Strangulated hernia,Hernias NEC,General system disorders NEC,Genrl,N
1534,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1534,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1535,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1535,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1536,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1536,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1536,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1537,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1537,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1538,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1538,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1539,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1539,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1539,3,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1539,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1539,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1539,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1539,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1540,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1541,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1541,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1542,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1542,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1542,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1542,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1543,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1543,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1543,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1543,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1543,5,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1543,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1543,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1544,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1544,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1544,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1544,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1544,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1544,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1544,7,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1545,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1546,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1546,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1547,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1548,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1548,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1548,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1548,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1548,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1548,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1548,7,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1548,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1548,9,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1548,10,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1548,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1548,12,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1548,13,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1548,14,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1548,15,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1549,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1550,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1550,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1550,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1550,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1550,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1551,1,Headache,Headaches NEC,Headaches,Nerv,N
1551,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1551,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1551,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1551,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1551,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1551,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1551,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1552,1,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1552,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1553,1,Enlarged uvula,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1553,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1553,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1553,4,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1553,5,Tonsillar inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1554,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1555,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1556,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1556,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1556,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1557,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1557,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1558,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1558,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1558,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1558,4,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1558,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1559,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1559,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1560,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1560,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1560,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1560,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1560,5,Headache,Headaches NEC,Headaches,Nerv,N
1560,6,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1560,7,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1560,8,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1561,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1561,2,Coronary artery bypass,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
1561,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1561,4,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1561,5,Sports injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1562,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1562,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1562,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1562,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1562,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1562,6,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1563,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1563,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1564,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1564,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1564,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1564,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1565,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1565,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1565,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1566,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1566,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1566,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1566,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1567,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1567,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1568,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1568,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1568,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1568,4,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1568,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1568,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1568,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1568,8,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1568,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1568,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1568,11,Tobacco poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1569,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1569,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1569,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1569,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1569,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1569,6,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1570,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1570,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1570,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1570,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1570,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1570,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1570,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1570,8,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1570,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1570,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1570,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1571,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1571,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1571,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1572,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1573,1,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1573,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1573,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1574,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1574,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1575,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1575,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1575,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1576,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1576,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1577,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1578,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1578,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1579,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1579,2,Claustrophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1579,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1579,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1579,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1580,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1580,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1580,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1580,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1581,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1582,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1582,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1583,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1583,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1584,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1584,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1585,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1585,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1586,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1586,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1587,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1587,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1587,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1587,4,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1587,5,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
1588,1,Migraine,Migraine headaches,Headaches,Nerv,N
1588,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1588,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1589,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1589,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1589,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1590,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1591,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1591,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1591,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1592,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1592,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1593,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1594,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1595,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1595,2,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1595,3,Dissociation,Dissociative states,Dissociative disorders,Psych,N
1595,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1595,5,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1595,6,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1595,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1595,8,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1595,9,Migraine,Migraine headaches,Headaches,Nerv,N
1595,10,Obsessive thoughts,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1595,11,Tobacco user,Tobacco use,Lifestyle issues,SocCi,N
1595,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1596,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1596,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1596,3,Headache,Headaches NEC,Headaches,Nerv,N
1597,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1598,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1598,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1598,3,Migraine,Migraine headaches,Headaches,Nerv,N
1598,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1599,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1599,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1599,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1600,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1600,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1600,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1600,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1601,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1601,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1601,3,Pharyngeal hypoaesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1601,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1601,5,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1601,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1602,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1602,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1602,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1603,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1604,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1604,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1605,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1605,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1605,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1605,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1606,1,Acne infantile,Acnes,Skin appendage conditions,Skin,N
1606,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1606,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1607,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1607,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1608,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1609,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1609,2,Laryngeal dysplasia,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1609,3,Myxoid cyst,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1609,4,Respiratory disorder neonatal,Newborn respiratory disorders NEC,Neonatal respiratory disorders,Resp,N
1610,1,Skin sensitisation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1611,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1611,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1611,3,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1611,4,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1611,5,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1611,6,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1611,7,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1611,8,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1611,9,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1611,10,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1612,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1613,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1613,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1614,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
1614,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1614,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1614,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1615,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1615,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1615,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1616,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1616,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1617,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1617,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1617,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1617,4,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1618,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1618,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1618,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1619,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1620,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1620,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1621,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1621,2,Hyperchlorhydria,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1621,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1621,4,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1621,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1622,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1622,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1622,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1622,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1623,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1624,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1625,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1625,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1625,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1625,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1625,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1625,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1626,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1627,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1627,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1627,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1627,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1627,5,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1628,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
1629,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1630,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1631,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1631,2,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1631,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1632,1,Conjunctivitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1632,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1632,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1632,4,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1632,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1632,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1632,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1633,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1633,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1633,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1633,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1633,5,Reaction to sweetener,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1633,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1634,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1634,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1634,3,Nasal injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1634,4,Nasal ulcer,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1634,5,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1635,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1635,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1635,3,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1636,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1636,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1636,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1636,4,Periodontal disease,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1636,5,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1637,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1637,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1638,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1638,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1638,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1638,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1638,5,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
1639,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1639,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1639,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1640,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1640,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1640,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1640,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1641,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1641,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1642,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1642,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1642,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1642,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1643,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1643,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1643,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1643,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1644,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
1644,2,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1644,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1644,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1644,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1644,6,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
1645,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1645,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1646,1,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1647,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1648,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1648,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1649,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1649,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1649,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1649,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1650,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1651,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1651,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1651,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1651,4,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1651,5,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1652,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1653,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1653,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1654,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1654,2,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1654,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1654,4,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1654,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1654,6,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1654,7,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1654,8,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1654,9,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1655,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1655,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
1655,3,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1655,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1655,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1655,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1655,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1655,8,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1656,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1656,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1657,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1658,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1658,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1658,3,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1658,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1659,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1659,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1660,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1660,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1660,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1660,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1660,5,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1660,6,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1660,7,Hyperaesthesia teeth,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1660,8,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1660,9,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1660,10,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1660,11,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1660,12,Snoring,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1660,13,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1661,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1661,2,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1661,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1661,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1662,1,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1662,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1662,3,Jaundice neonatal,Neonatal hepatobiliary disorders,Neonatal and perinatal conditions,Preg,N
1662,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1663,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1663,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1664,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1664,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1665,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1665,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1666,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1666,2,Blister rupture,Bullous conditions,Epidermal and dermal conditions,Skin,N
1666,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1666,4,Tonsillar haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1667,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1667,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1667,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1668,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1668,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1668,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1669,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1669,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1670,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1670,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1670,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1671,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1671,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1671,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1672,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1672,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1672,3,Tooth restoration,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1673,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1673,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1673,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1673,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1674,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1674,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1674,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1674,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1674,5,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1675,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1675,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1676,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1676,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1676,3,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1676,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1676,5,Bipolar I disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
1676,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1676,7,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1676,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1676,9,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1676,10,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1676,11,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1676,12,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1676,13,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1676,14,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1676,15,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1676,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1676,17,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1676,18,Feelings of worthlessness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1676,19,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1676,20,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1676,21,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1676,22,Increased upper airway secretion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1676,23,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1676,24,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1676,25,Judgement impaired,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1676,26,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1676,27,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1676,28,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1676,29,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1676,30,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1676,31,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1676,32,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1676,33,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1676,34,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1676,35,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1676,36,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1676,37,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1676,38,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1676,39,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1676,40,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1676,41,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1676,42,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1676,43,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1676,44,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1676,45,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1676,46,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1676,47,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1677,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1678,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1679,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1680,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1681,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1681,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1681,3,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
1681,4,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1681,5,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1682,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1683,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1684,1,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
1685,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1686,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1686,2,Tobacco user,Tobacco use,Lifestyle issues,SocCi,N
1687,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1687,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1687,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1687,4,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1688,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1688,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1689,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1690,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1690,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1690,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1691,1,Headache,Headaches NEC,Headaches,Nerv,N
1691,2,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1691,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1692,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
1692,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1692,3,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1692,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1692,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1692,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1692,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1692,8,Mitral valve disease,Mitral valvular disorders,Cardiac valve disorders,Card,N
1692,9,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1693,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1693,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1693,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1693,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1694,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1694,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1694,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1695,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1695,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1695,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1695,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1695,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1695,6,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1696,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1696,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1696,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1697,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1697,2,Social problem,Social issues NEC,Lifestyle issues,SocCi,N
1698,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1698,2,Tobacco user,Tobacco use,Lifestyle issues,SocCi,N
1699,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1699,2,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1700,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1701,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1701,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1701,3,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1701,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1702,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1703,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1703,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1704,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1704,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1705,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1705,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1706,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1707,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1707,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1708,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1709,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1710,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1710,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1710,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1711,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1711,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1712,1,Headache,Headaches NEC,Headaches,Nerv,N
1712,2,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1713,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1714,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1714,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1714,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1715,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1715,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1716,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1716,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1716,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1717,1,Facial spasm,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1717,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1717,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1718,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1719,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1719,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1719,3,Headache,Headaches NEC,Headaches,Nerv,N
1719,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1720,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1721,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1721,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1722,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1722,2,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
1723,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1724,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1724,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1725,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1725,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1726,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1726,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1726,3,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1726,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1727,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1728,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1728,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1729,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1729,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1729,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1730,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1730,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1730,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1731,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1731,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1731,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1731,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1732,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1733,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1733,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1734,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1734,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1734,3,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1734,4,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1734,5,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1734,6,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1734,7,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1734,8,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1734,9,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1734,10,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1734,11,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1734,12,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1734,13,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1734,14,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1734,15,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1734,16,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1734,17,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1734,18,Complication of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1734,19,Complication of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1734,20,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1734,21,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1734,22,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1734,23,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1734,24,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1734,25,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1734,26,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1734,27,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1734,28,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1734,29,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1734,30,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1734,31,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1734,32,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1734,33,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1734,34,Headache,Headaches NEC,Headaches,Nerv,N
1734,35,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1734,36,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1734,37,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1734,38,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1734,39,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1734,40,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1734,41,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1734,42,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1734,43,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1734,44,Migraine,Migraine headaches,Headaches,Nerv,N
1734,45,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1734,46,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1734,47,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1734,48,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1734,49,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1734,50,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1734,51,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1734,52,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1734,53,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1734,54,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1734,55,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1734,56,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1734,57,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1734,58,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1734,59,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
1734,60,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
1734,61,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1734,62,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1734,63,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1734,64,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1734,65,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1734,66,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1734,67,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1734,68,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1734,69,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1734,70,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1734,71,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1734,72,Symphysiolysis,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
1734,73,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1734,74,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1734,75,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1734,76,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1734,77,Ultrasound Doppler abnormal,Vascular imaging procedures NEC,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1734,78,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1734,79,Uterine contractions abnormal,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
1734,80,Uterine contractions abnormal,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
1734,81,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1734,82,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1734,83,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1734,84,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1734,85,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1734,86,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1734,87,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1734,88,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1734,89,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1734,90,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1735,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1735,2,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1735,3,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1735,4,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1735,5,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1735,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1735,7,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1735,8,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1735,9,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1735,10,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1735,11,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1735,12,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1735,13,Complication of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
1735,14,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1735,15,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1735,16,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1735,17,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1735,18,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1735,19,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1735,20,Eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1735,21,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1735,22,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1735,23,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1735,24,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1735,25,Headache,Headaches NEC,Headaches,Nerv,N
1735,26,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1735,27,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1735,28,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1735,29,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1735,30,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1735,31,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1735,32,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1735,33,Migraine,Migraine headaches,Headaches,Nerv,N
1735,34,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1735,35,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1735,36,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1735,37,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1735,38,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1735,39,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1735,40,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1735,41,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1735,42,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1735,43,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1735,44,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1735,45,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1735,46,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
1735,47,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1735,48,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1735,49,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1735,50,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
1735,51,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1735,52,Pyelonephritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1735,53,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1735,54,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1735,55,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1735,56,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1735,57,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1735,58,Symphysiolysis,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
1735,59,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1735,60,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1735,61,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1735,62,Ultrasound Doppler abnormal,Vascular imaging procedures NEC,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1735,63,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1735,64,Uterine contractions abnormal,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
1735,65,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1735,66,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1735,67,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
1735,68,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1735,69,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1735,70,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1735,71,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1735,72,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1736,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1736,2,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1736,3,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1736,4,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1736,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1736,6,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1736,7,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
1736,8,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1736,9,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
1736,10,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1736,11,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1736,12,Deafness congenital,Hearing disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
1736,13,Death neonatal,Death and sudden death,Fatal outcomes,Genrl,Y
1736,14,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1736,15,Disability,Disability issues,Lifestyle issues,SocCi,N
1736,16,Fallot's tetralogy,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,N
1736,17,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1736,18,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1736,19,Foetal heart rate deceleration abnormality,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1736,20,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1736,21,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1736,22,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1736,23,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1736,24,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
1736,25,Infantile apnoea,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1736,26,Injury to brachial plexus due to birth trauma,Peripheral nerve injuries,Injuries NEC,Inj&P,N
1736,27,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1736,28,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1736,29,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1736,30,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1736,31,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
1736,32,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1736,33,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1736,34,Neonatal seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1736,35,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1736,36,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1736,37,Pyelocaliectasis,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
1736,38,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1736,39,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1736,40,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1736,41,Shoulder dystocia,Foetal position and presentation abnormalities,Foetal complications,Preg,N
1736,42,Syndactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1736,43,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1736,44,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1736,45,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1736,46,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1736,47,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1737,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1737,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1737,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1737,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1737,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1738,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1738,2,Cholinergic syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1739,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1739,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1739,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1739,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1739,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1739,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1740,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1741,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1741,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1741,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1741,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1741,5,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1741,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1741,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1741,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1741,9,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1742,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
1743,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1743,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1743,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1744,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1745,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1745,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1746,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1746,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1747,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1748,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1748,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1749,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1749,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1749,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1750,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1750,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1750,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1750,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1751,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1751,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1752,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1752,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1752,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1752,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1752,5,Temporomandibular pain and dysfunction syndrome,Joint related disorders NEC,Joint disorders,Musc,N
1753,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1754,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1755,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1755,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1755,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1755,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1755,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1755,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1755,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1755,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1755,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1755,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1756,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1756,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1756,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1757,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1758,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1758,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1759,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1759,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1759,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1760,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1761,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1761,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1761,3,Pharyngeal hypoaesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1761,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1761,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1761,6,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
1762,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1762,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1762,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1763,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1764,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1764,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1765,1,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1766,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1766,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1766,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1767,1,Cataract congenital,Lens disorders congenital,Eye disorders congenital,Cong,N
1767,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1768,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1768,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1769,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1769,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1770,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1770,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1771,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1771,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1772,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1772,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1772,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1773,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1773,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1774,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1774,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1774,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1774,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1774,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1774,6,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1774,7,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1774,8,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1774,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1774,10,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1774,11,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1774,12,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1774,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1774,14,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1775,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1776,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1776,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
1777,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1777,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1777,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1777,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1777,5,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1777,6,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1777,7,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1778,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1778,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1778,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1778,4,Headache,Headaches NEC,Headaches,Nerv,N
1778,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1778,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1778,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1778,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1779,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1779,2,Respiratory tract malformation,Respiratory tract disorders congenital NEC,Respiratory disorders congenital,Cong,N
1780,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1781,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1781,2,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1782,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1783,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1783,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1784,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1785,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1786,1,Abscess oral,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1786,2,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
1787,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1787,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1787,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1788,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1788,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1788,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1788,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1788,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1789,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1789,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1789,3,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1790,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1790,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1790,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1791,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1792,1,Facial operation,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1792,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1793,1,Facial operation,Facial therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1793,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1794,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1794,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1795,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1795,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1795,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1795,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1795,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1795,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1796,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1796,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1796,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1797,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1798,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1799,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1800,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1800,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1800,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1800,4,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1800,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1800,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1801,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1801,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1802,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1803,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1803,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1804,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1804,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1805,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1805,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1805,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1806,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1806,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1806,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1807,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1807,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1808,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1808,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1808,3,Headache,Headaches NEC,Headaches,Nerv,N
1808,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1808,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1809,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1809,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1809,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1809,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1809,5,Poor dental condition,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1809,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1810,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1810,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1810,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1810,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1810,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1810,8,Migraine,Migraine headaches,Headaches,Nerv,N
1810,9,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1810,10,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1810,11,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,12,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1811,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1812,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1813,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1813,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1814,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1814,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1815,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1815,2,Foreign body in gastrointestinal tract,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1815,3,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1816,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1816,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1817,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1817,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1818,1,Dental restoration failure,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1818,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1818,3,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1818,4,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1819,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1820,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1820,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1820,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1821,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1822,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1822,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1822,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1823,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1824,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1824,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1824,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1824,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1824,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1825,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1826,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1826,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1826,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1826,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1826,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1826,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1827,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1828,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1828,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1829,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1830,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1830,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1831,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1832,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1832,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1832,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1832,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1832,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1833,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1834,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1834,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1834,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1834,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1834,5,Tobacco poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1835,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1835,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1835,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1836,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1836,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1836,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1837,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1838,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1838,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1839,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1840,1,Foreign body in gastrointestinal tract,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1841,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1841,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1842,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1842,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1843,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1844,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1845,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1845,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1846,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1846,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1846,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1847,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1847,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1847,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1848,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1848,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1848,3,Tobacco abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1848,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1849,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1849,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1850,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1850,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1851,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1851,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1851,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1851,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1851,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1851,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1851,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1851,8,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1851,9,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1851,10,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1851,11,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1851,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1852,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1852,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1852,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1852,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1853,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1853,2,Burn oral cavity,Thermal burns,Injuries by physical agents,Inj&P,N
1853,3,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
1853,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1854,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1854,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1855,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
1855,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1855,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1855,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1856,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1856,2,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1857,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1857,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1858,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1859,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1859,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1860,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1860,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1861,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1861,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1862,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1863,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1863,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1864,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1864,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1864,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1865,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1866,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1866,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1867,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1867,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1867,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1867,4,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1867,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1868,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1869,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1870,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1871,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1872,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1872,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1872,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1873,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1873,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1873,3,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1873,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1873,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1874,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1874,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1874,3,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1874,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1874,5,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1875,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1876,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
1877,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1877,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1877,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1878,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1878,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1878,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1879,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1879,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1880,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1880,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1880,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1881,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1882,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1882,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1882,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1883,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1883,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1884,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1885,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1886,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1886,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1887,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1887,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1887,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1887,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1887,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1888,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1888,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1888,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1889,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1889,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1890,1,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1891,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1891,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1892,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1893,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1893,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1893,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1893,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1893,5,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1893,6,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1894,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
1894,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1894,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1894,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1894,5,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1894,6,Muscle injury,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1894,7,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1894,8,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1894,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1894,10,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1894,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1894,12,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1894,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1894,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1894,15,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1894,16,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1894,17,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1895,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1895,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1896,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1897,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1898,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1899,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1899,2,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1900,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1900,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1901,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1901,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1902,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1903,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1904,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1904,2,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1904,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1904,4,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1905,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1905,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1905,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1906,1,Headache,Headaches NEC,Headaches,Nerv,N
1907,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1908,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1908,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1908,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1909,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1910,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1911,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1912,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
1912,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1913,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1914,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1914,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1914,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1914,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1915,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1915,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1915,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1916,1,Migraine,Migraine headaches,Headaches,Nerv,N
1916,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1917,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1917,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1917,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1918,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1918,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1918,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1918,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1918,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1918,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1919,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1919,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1919,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1920,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1921,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
1921,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1921,3,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1921,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1921,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
1922,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1922,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1922,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1922,4,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1923,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1923,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1923,3,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1924,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1924,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1924,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1925,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
1925,2,Blister infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1925,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1926,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1927,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1927,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1928,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1928,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1928,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1929,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1929,2,Dental implantation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
1929,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1929,4,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1929,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1930,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1930,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1930,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1930,4,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1931,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1932,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1933,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1933,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1933,3,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1934,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1934,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1934,3,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1935,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1935,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1936,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1936,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1937,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1938,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1938,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1938,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1939,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1939,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1940,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1941,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1942,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1942,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1943,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1944,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1944,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1944,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1945,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1946,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1946,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1946,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1947,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1947,2,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1948,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1949,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1949,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1950,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1951,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1952,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1953,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1954,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1954,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1955,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1955,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1956,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1956,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1957,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1957,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1958,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1958,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1958,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1959,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1960,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1960,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1961,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1962,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1963,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1963,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1964,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1964,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1964,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1965,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1966,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1966,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1966,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1967,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1968,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1968,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1969,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1969,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1970,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1970,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1971,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1972,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1973,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1973,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1973,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1973,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1973,5,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1973,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1974,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1974,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1974,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
1975,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1975,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1976,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1977,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1977,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1977,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1977,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1978,1,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1979,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1979,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1980,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1980,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1980,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1981,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1981,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1982,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1983,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1983,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1983,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1984,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1984,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1984,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
1985,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1985,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1986,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1986,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1987,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1987,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1988,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1988,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1988,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1989,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1989,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1990,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1990,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1990,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1991,1,Chemical burn of oral cavity,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
1991,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1992,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1992,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1993,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1993,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1993,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1994,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1995,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1995,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1995,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1995,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1995,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1995,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1995,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1995,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
1995,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1996,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1996,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1997,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1998,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1998,2,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1998,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1999,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1999,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2000,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2001,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2001,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2002,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2002,2,Headache,Headaches NEC,Headaches,Nerv,N
2002,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2002,4,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
2002,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2003,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2004,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2004,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2005,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2006,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2006,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2007,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2007,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2008,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2009,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2010,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2010,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2011,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2011,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2012,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2012,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2013,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2013,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2013,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2014,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2014,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2014,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2015,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2015,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2015,3,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2015,4,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2016,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2016,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2017,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2017,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2018,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2019,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2019,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2020,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2021,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2022,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2022,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2023,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2024,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2025,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2025,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2026,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2027,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2028,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2028,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2029,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2030,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2030,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2031,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2031,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2032,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2033,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2033,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2033,3,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2034,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2035,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2036,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2036,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2036,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2036,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2036,5,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2037,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2037,2,Headache,Headaches NEC,Headaches,Nerv,N
2037,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2038,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2038,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2039,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2040,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2040,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2040,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2040,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2040,5,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2041,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2042,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2042,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2042,3,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2042,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2043,1,Catarrh,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2043,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2043,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2043,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2043,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2043,6,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2043,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2044,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2045,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2046,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2046,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2047,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2047,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2048,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2048,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2049,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2049,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2049,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2050,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2051,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2051,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2051,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2051,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2052,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2052,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2052,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2053,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2053,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2054,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2054,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2055,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2055,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2056,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2057,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2057,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2057,3,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2057,4,Headache,Headaches NEC,Headaches,Nerv,N
2057,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2057,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2058,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2058,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2058,3,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2059,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2060,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2060,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2060,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2060,4,Pharyngeal paraesthesia,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2060,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2060,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2061,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2061,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2062,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2062,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2063,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2064,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2064,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2064,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2064,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2065,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2066,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2066,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2067,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2067,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2068,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2068,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2068,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2069,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2069,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2070,1,Burn oral cavity,Thermal burns,Injuries by physical agents,Inj&P,N
2070,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2070,3,Gingival erosion,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2070,4,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2071,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2072,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2073,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2074,1,Gastric perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2075,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2075,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2076,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2076,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2076,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2077,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2078,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2078,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2078,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2079,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2079,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2079,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2079,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2080,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2080,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2081,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2082,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
2083,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2084,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2084,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2085,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2085,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2086,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2086,2,Headache,Headaches NEC,Headaches,Nerv,N
2086,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2086,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2086,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2087,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2087,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2088,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2088,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2089,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2089,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2089,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2089,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2089,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2090,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2090,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2090,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2091,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2091,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2092,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2092,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2092,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2092,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2092,5,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2092,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2092,7,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2092,8,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2092,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2092,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2093,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,Y
2093,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2093,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2094,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2094,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2095,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2096,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2096,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2097,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2097,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2097,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2098,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2098,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2098,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2099,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2099,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2099,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2100,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2100,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2100,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2101,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2101,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2101,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2102,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2102,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2102,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2103,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2103,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2103,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2104,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2105,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2105,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2106,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2106,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2106,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2106,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2106,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2106,6,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2106,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2106,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2106,9,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2107,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2108,1,Administration site injury,Administration site reactions NEC,Administration site reactions,Genrl,N
2109,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2109,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2109,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2109,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2109,5,Suspected product tampering,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2110,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2110,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2110,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2110,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2111,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2111,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2112,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2112,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2113,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2113,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2113,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
2114,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2115,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2116,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2116,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2116,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2117,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2118,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2119,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2119,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2120,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2121,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2122,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
2123,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2123,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2123,3,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2124,1,Pharyngeal injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2124,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2125,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2126,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2126,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2126,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2126,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2127,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2127,2,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2128,1,Headache,Headaches NEC,Headaches,Nerv,N
2128,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2129,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2129,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2129,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2129,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2129,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2129,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2130,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2130,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2131,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2131,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2131,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2131,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2132,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2132,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2133,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2133,2,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2134,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2135,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2136,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2136,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2136,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2136,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2136,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2137,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2138,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2139,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2139,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2140,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2140,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2141,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2141,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2142,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2142,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2143,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2143,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2144,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2144,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2144,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2144,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2145,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2146,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2146,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2146,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2147,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2147,2,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2148,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2148,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2148,3,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2149,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2149,2,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2149,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2149,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2149,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2150,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2150,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2151,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2152,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2153,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2153,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2154,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2155,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
2156,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2156,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2156,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2156,4,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2157,1,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2157,2,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2158,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2158,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2158,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2158,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2159,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2159,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2159,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2159,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2159,6,Headache,Headaches NEC,Headaches,Nerv,N
2159,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2159,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2159,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2159,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2159,11,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2159,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2160,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2160,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2160,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2160,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2160,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2160,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2161,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2162,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2162,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2163,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2164,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2165,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2166,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2167,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2167,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2168,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2168,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2168,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2168,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2168,5,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2169,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2170,1,Anal fissure,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
2170,2,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2170,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2171,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2172,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2172,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2172,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2172,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2172,5,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2172,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2173,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2174,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2174,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2175,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2175,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2176,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2177,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
2177,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2178,1,Cataplexy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2178,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2178,3,Narcolepsy,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2178,4,Sleep paralysis,Abnormal sleep-related events,Sleep disturbances (incl subtypes),Nerv,N
2179,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2180,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2180,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2180,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2180,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2180,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2180,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2181,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2182,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2182,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2183,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2184,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2184,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2184,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2184,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2185,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2186,1,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
2187,1,Burns third degree,Thermal burns,Injuries by physical agents,Inj&P,N
2188,1,Discoloured vomit,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2188,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2188,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2189,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2189,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2189,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2189,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2189,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2189,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2189,7,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2189,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2189,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2189,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2189,11,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2189,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2189,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2189,14,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2190,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2190,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2191,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2191,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2191,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2192,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2193,1,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2193,2,Oropharyngeal blistering,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2193,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2194,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2194,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2194,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2195,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2195,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2196,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2196,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2197,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2198,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2198,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2199,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2199,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2199,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2199,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2200,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2200,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2200,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2200,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2201,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
2202,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2202,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2203,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2203,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2204,1,Headache,Headaches NEC,Headaches,Nerv,N
2204,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
2204,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2204,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2205,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2205,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2206,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2206,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2207,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2207,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2208,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2209,1,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2210,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2210,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2211,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2211,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2212,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2212,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2212,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2212,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2212,5,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2212,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2213,1,Arteriosclerosis,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2213,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2213,3,Postmortem blood drug level increased,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
2213,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2214,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2214,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2214,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2215,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2216,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2217,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2217,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2217,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2218,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2219,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2219,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2219,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2220,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2220,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2221,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2221,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2221,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2221,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2222,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2223,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2224,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2224,2,Device ineffective,Device issues NEC,Device issues,Prod,N
2225,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2226,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
2226,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2226,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2226,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2227,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2227,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2228,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
2229,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2230,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2230,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2230,3,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2230,4,Headache,Headaches NEC,Headaches,Nerv,N
2230,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2230,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2231,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2231,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2231,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2232,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2232,2,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2232,3,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2232,4,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2233,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2233,2,Headache,Headaches NEC,Headaches,Nerv,N
2234,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2234,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2235,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2235,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2236,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2236,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2237,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2237,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2238,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2238,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2238,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2239,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2240,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2241,1,Headache,Headaches NEC,Headaches,Nerv,N
2241,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2241,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2241,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2242,1,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2243,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2244,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2244,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2244,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2245,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2246,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2246,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2246,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2247,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2247,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2247,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2248,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2248,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2248,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2249,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2249,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2250,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2250,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2251,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2252,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2253,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2253,2,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2254,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2255,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2256,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2256,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2256,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2256,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2257,1,Headache,Headaches NEC,Headaches,Nerv,N
2258,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2258,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2259,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2260,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2260,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2261,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2262,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2262,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2262,3,Medical device site erosion,Complications associated with device NEC,Complications associated with device,Genrl,N
2262,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2262,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2262,6,Skin graft,Skin grafts,Skin and subcutaneous tissue therapeutic procedures,Surg,N
2263,1,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2263,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2263,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2264,1,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2264,2,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2264,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2265,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2265,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2265,3,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2265,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2265,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2266,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
2266,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2266,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2266,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2267,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2267,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2267,3,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2268,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2268,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2268,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2269,1,Nail injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2269,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2269,3,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2270,1,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2271,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2272,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2272,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2273,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2273,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2274,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2275,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2275,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2275,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2275,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2276,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2276,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2277,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2277,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2277,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2277,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2277,5,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2278,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2278,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2278,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2279,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2279,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2280,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2280,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2281,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2281,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2282,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2283,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2284,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2285,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2285,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2286,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2286,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2287,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2287,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2288,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2288,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2288,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2289,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2289,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2290,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2290,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2290,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2291,1,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2292,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2293,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2293,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2293,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2293,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2293,5,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2294,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2294,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2295,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2296,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2296,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2297,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2297,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2297,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2298,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2299,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2300,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2300,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2301,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2302,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2302,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2303,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2304,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2304,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2304,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2305,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2305,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2306,1,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2306,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2307,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2307,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2307,3,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2308,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2308,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2308,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2309,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2309,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2310,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2311,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2312,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2312,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2312,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2313,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2314,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2315,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2315,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2315,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2315,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2315,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2316,1,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2317,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2317,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2318,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2319,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2320,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2320,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2320,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2321,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2321,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2322,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2322,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2323,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2323,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2324,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2324,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2324,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2324,4,Headache,Headaches NEC,Headaches,Nerv,N
2324,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2324,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2325,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2326,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2327,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2328,1,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2329,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2330,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2331,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2331,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2332,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2332,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2332,3,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2332,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2333,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2333,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2333,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2333,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2334,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2334,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2334,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2335,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2335,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2335,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2336,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2336,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2337,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2338,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2339,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2340,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2340,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2341,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2341,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2342,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2343,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2343,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2343,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2344,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2344,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2345,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2345,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2346,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2346,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2347,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2348,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2349,1,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
2349,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2350,1,Breath holding,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2350,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2351,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2352,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2352,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2353,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2353,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2354,1,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2355,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2356,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2356,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2356,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2356,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2356,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2356,6,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2357,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2357,2,Headache,Headaches NEC,Headaches,Nerv,N
2357,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2357,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2358,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2358,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2359,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2359,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2360,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2360,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2360,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2361,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2362,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2363,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2364,1,Headache,Headaches NEC,Headaches,Nerv,N
2364,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2364,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2364,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2364,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2364,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2365,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2365,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2366,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2367,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2367,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2368,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2369,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2369,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2370,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2370,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2370,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2371,1,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
2371,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2372,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2372,2,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2372,3,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2372,4,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2372,5,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2372,6,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2372,7,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2372,8,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2373,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2373,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2374,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2374,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2375,1,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2375,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2376,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2377,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2377,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2377,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2378,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2379,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2379,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2380,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2381,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2381,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2381,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2382,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2382,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2383,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2384,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
2385,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2386,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2386,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2386,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2386,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2386,5,Purulence,Infections NEC,Infections - pathogen unspecified,Infec,N
2387,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2388,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2388,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2388,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2388,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2388,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2388,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2388,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2388,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2388,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
2389,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2390,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2390,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2390,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2391,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2392,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
2392,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2393,1,Nail injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2393,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2393,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2394,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2394,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2395,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2396,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2396,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2397,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2397,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2397,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2398,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2398,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2399,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2399,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2399,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2400,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2400,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2401,1,Oral mucosal discolouration,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2402,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2403,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2404,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2405,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2405,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2405,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2406,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2407,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2408,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2408,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2408,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2408,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2409,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2409,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2410,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2410,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2410,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2410,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2410,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2411,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2411,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2411,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2411,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2411,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2412,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2412,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2412,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2413,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2414,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2414,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2414,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2414,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2414,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2414,6,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2414,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2414,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2415,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2416,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2417,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2417,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2417,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2417,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2417,5,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2418,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2418,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2418,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2419,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2420,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2420,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2420,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2421,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2421,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2422,1,Application site dermatitis,Application site reactions,Administration site reactions,Genrl,N
2422,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2422,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2422,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2422,5,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2422,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2422,7,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2423,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2424,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2424,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2424,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2425,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2425,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2426,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2426,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2427,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
2428,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2429,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2429,2,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2429,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2430,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2430,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2431,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2432,1,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2432,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2433,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2434,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2435,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2436,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2437,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2438,1,Mouth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2438,2,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2439,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2440,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2440,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2440,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2441,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2442,1,Gingival recession,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2442,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2443,1,Breath alcohol test positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
2444,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2445,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2446,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2446,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2446,3,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2447,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
2447,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2448,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2448,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
2448,3,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2448,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2449,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2450,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2450,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2451,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2451,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2451,3,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2452,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2452,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2453,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2454,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2455,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2455,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2455,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2455,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2455,5,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2456,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2456,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2456,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2457,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2457,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2457,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2458,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2458,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2458,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2459,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2459,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2459,3,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2460,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2460,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2461,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2462,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2463,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2464,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2464,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2464,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2464,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2465,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2465,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2465,3,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2465,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2466,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2466,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2467,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2468,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2469,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2469,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2469,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2469,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2470,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2471,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2471,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2471,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2472,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2472,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2473,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2473,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2474,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2474,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2474,3,Application site scab,Application site reactions,Administration site reactions,Genrl,N
2474,4,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2474,5,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2475,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2476,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2476,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2476,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2476,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2476,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2476,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2477,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2478,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2478,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2478,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2478,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2479,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2480,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2481,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2481,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2481,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2481,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2482,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2483,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2483,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2483,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2483,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2484,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2484,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2484,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2485,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2486,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2486,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2486,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2487,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2487,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2487,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2487,4,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2488,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2489,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2489,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2489,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2490,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2490,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2491,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2491,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2491,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2491,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2492,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2493,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2494,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2494,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2494,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2494,4,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2495,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2496,1,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2497,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
2498,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2498,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2498,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2498,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2498,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2499,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2499,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2500,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2501,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2501,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2501,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2502,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2502,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2503,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2503,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2504,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2505,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2505,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2505,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2506,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2506,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2507,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2508,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2509,1,Headache,Headaches NEC,Headaches,Nerv,N
2509,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2510,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2510,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2510,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2510,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2511,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2511,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2511,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2511,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2512,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2512,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2512,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2513,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2513,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2514,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2514,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2515,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2516,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2516,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2517,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2517,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2517,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2517,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2517,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2517,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2517,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2517,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2517,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
2518,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2518,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2519,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2519,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2520,1,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2520,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2520,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2521,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2521,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2521,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2522,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2522,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2523,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2523,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2524,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2524,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2525,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2526,1,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2527,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2528,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2528,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2528,3,Headache,Headaches NEC,Headaches,Nerv,N
2528,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2528,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2529,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2530,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2530,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2530,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2530,4,Headache,Headaches NEC,Headaches,Nerv,N
2531,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2532,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2533,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2533,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2533,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2533,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2533,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2534,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2534,2,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2535,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2535,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2535,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2536,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2536,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2536,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2536,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2536,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2536,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2536,7,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2536,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2536,9,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2537,1,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
2537,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2537,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2538,1,Chemical burn,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
2539,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
2539,2,Hanging,Death and sudden death,Fatal outcomes,Genrl,N
2540,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2541,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2542,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2543,1,Application site haemorrhage,Application site reactions,Administration site reactions,Genrl,N
2543,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2543,3,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2543,4,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2544,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2544,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2544,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2544,4,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2545,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2546,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2547,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2548,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2549,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2550,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2551,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2552,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2552,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2553,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2553,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2553,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2554,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2555,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2556,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2556,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2557,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2557,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2557,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2557,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2558,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2559,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2559,2,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
2559,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2559,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2559,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2560,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2560,2,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2560,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2561,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2562,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2563,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2564,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2565,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2565,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2565,3,Headache,Headaches NEC,Headaches,Nerv,N
2565,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2565,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2565,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2565,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2566,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2566,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2567,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2568,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2568,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2569,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2569,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2569,3,Headache,Headaches NEC,Headaches,Nerv,N
2569,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2569,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2569,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2569,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2570,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2571,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2571,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2572,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2572,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2573,1,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2573,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2574,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2574,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2574,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2574,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2575,1,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2576,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2576,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2577,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2578,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2579,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2580,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2580,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2580,3,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2581,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2581,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2582,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2582,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2582,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2582,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2582,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2582,6,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2582,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2582,8,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2582,9,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2583,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2583,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2584,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2584,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2585,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2585,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2586,1,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
2587,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2587,2,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2588,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2588,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2588,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2589,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2590,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2591,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2591,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2591,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2591,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2591,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2592,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2592,2,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2592,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2592,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2593,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2593,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2593,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2593,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2594,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2594,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2594,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2595,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2595,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2595,3,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2596,1,Gingival discomfort,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2596,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2596,3,Product package associated injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2596,4,Product packaging difficult to open,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2596,5,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2597,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2597,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2598,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2599,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2600,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2601,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2601,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2602,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2602,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2602,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2603,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2603,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2603,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2604,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2604,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2604,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2604,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2604,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2605,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2606,1,Breath sounds abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2606,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2606,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2606,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2606,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2607,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2607,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2608,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2608,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2609,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2609,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2610,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2610,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2610,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2611,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2611,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2612,1,Coating in mouth,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2612,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2612,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2612,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2612,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2612,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2612,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2613,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2613,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2613,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2613,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2614,1,Drug tolerance increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2614,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2614,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2614,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2614,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2615,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2616,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2616,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2617,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2618,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2618,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2618,3,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2619,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2620,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2621,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2621,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2621,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2621,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2622,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2623,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2623,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2623,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2623,4,Wrong patient received product,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2624,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2624,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2625,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2625,2,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2625,3,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2626,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2627,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2627,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2628,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2629,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2629,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2629,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2630,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2630,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2630,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2630,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2631,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2632,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2633,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2634,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2634,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2635,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2635,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2635,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2636,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2636,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2637,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2637,2,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2638,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2639,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2640,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2640,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2641,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2642,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2643,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2643,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2644,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2645,1,Allergic oedema,Allergic conditions NEC,Allergic conditions,Immun,N
2646,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2647,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2647,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2647,3,Headache,Headaches NEC,Headaches,Nerv,N
2648,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2648,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2649,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2649,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2650,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2650,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2651,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2651,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2651,3,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
2651,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2652,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2652,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2653,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2654,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2654,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2655,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2656,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2657,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2657,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2658,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2658,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2659,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
2659,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2659,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2660,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2660,2,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2660,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2661,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2662,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2662,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2662,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2662,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2662,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2663,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2664,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2664,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2664,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2665,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2666,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2666,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2666,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2666,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2666,5,Headache,Headaches NEC,Headaches,Nerv,N
2666,6,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2666,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2666,8,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2666,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2666,10,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2666,11,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
2666,12,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2667,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2667,2,Application site exfoliation,Application site reactions,Administration site reactions,Genrl,N
2667,3,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2668,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2668,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2669,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2670,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2670,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2671,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2672,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2673,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2674,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2675,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2675,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2675,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2675,4,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
2676,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2676,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2676,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2676,4,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2676,5,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2677,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2677,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2678,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2678,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2678,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2678,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2678,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2679,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2679,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2680,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2681,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2681,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2681,3,Skin discomfort,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2681,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2682,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2683,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2684,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2685,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
2685,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2686,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2686,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2686,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2686,4,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2687,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2687,2,Headache,Headaches NEC,Headaches,Nerv,N
2687,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2687,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2687,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2688,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2689,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2689,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2689,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2689,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2690,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2690,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2691,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2692,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2693,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2694,1,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2695,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2695,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2695,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2696,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
2697,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2698,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2698,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2698,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2698,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2699,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2700,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2701,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2702,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
2703,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2704,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2704,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2704,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2705,1,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
2706,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2706,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2707,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2707,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2708,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2709,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2710,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2711,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2712,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2712,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2713,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2713,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2713,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2713,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2714,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2714,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2714,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2714,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2714,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2714,6,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2714,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2714,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2715,1,Device allergy,Allergic conditions NEC,Allergic conditions,Immun,N
2716,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2716,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2716,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2717,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2718,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2718,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2719,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2719,2,Application site induration,Application site reactions,Administration site reactions,Genrl,N
2719,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2719,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2720,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2721,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2722,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2722,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2723,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2724,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2724,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2724,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2725,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2725,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2726,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2727,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2727,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2728,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2728,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2728,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2728,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2729,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2730,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2731,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2731,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2732,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2733,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2734,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2735,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2735,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2736,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2737,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2738,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2739,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2740,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2740,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2741,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2741,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2741,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2742,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2743,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2743,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2743,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2744,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2744,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2744,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2745,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2745,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2745,3,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2745,4,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2746,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2747,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2748,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2748,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2748,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2749,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2750,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2751,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2751,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2751,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2751,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2752,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2752,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2753,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2754,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2755,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2756,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2757,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2758,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2759,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2760,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2761,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2761,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2762,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2763,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2764,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2764,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2765,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2765,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2766,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2767,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2767,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2768,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2768,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2769,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2769,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2770,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2770,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2770,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2771,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2771,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2772,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2772,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2773,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2773,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2773,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2774,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2775,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2775,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2775,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2776,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2776,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2776,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2776,4,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2776,5,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2776,6,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2776,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2777,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2777,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2778,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2778,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2779,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2780,1,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
2781,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2781,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2781,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2781,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2782,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2783,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2784,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2785,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2786,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2786,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2786,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2786,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2787,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2788,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2789,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2790,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2791,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2792,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2792,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2792,3,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2793,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2794,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2794,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2795,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2796,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2796,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2797,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2798,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2798,2,Application site ulcer,Application site reactions,Administration site reactions,Genrl,N
2799,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
2799,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2799,3,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2799,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2800,1,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
2801,1,Application site hypoaesthesia,Application site reactions,Administration site reactions,Genrl,N
2801,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2802,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2802,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2802,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2803,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2803,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2803,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2804,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2805,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2806,1,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
2806,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2806,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2807,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2807,2,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
2808,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2808,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2808,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2808,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2808,5,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2809,1,Application site mass,Application site reactions,Administration site reactions,Genrl,N
2809,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2810,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2810,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2810,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2811,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2811,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2811,3,Skin pressure mark,Skin injuries NEC,Injuries NEC,Inj&P,N
2812,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2812,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2812,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2813,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2813,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
2813,3,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
2814,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2815,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2815,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2816,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2817,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2818,1,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
2819,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2820,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2821,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2822,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2823,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2824,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2825,1,Application site scar,Application site reactions,Administration site reactions,Genrl,N
2826,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2826,2,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2827,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2827,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2827,3,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2828,1,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2829,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2830,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2830,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2831,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2832,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2832,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2832,3,Headache,Headaches NEC,Headaches,Nerv,N
2832,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2832,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2833,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2834,1,Headache,Headaches NEC,Headaches,Nerv,N
2834,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2835,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2835,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2836,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2836,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2836,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2836,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2836,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2837,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2838,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2838,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2839,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2840,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2841,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2842,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2842,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2842,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2843,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2844,1,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2845,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
2846,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2846,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2846,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2847,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2847,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2848,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2849,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2850,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2850,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2851,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2852,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2852,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2852,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2852,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2853,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2853,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2853,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2853,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2853,5,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2854,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2854,2,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2854,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2855,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2856,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2856,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2857,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2858,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2858,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2859,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2860,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2861,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2862,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2863,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2863,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2864,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2865,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2866,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2867,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2867,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2868,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2869,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2870,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2870,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2871,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2871,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2872,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2872,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2872,3,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2873,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2874,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2875,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2875,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2875,3,Oesophageal irritation,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2876,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2877,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2878,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2878,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2879,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2880,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2880,2,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2880,3,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2881,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2881,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2882,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
2883,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2884,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2884,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2885,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2886,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2887,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2888,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2889,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2890,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2891,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2892,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2893,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2893,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2894,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2895,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2896,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2897,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2897,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2897,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2897,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2897,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2897,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2898,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2899,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2899,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2900,1,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2901,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2901,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2902,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2902,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2903,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2903,2,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2904,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2904,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2904,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2905,1,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2905,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2906,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2906,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2906,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2906,4,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2906,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2907,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2908,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2909,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2910,1,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2911,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2912,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2912,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2913,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2913,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2913,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2914,1,Application site paraesthesia,Application site reactions,Administration site reactions,Genrl,N
2915,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2915,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2916,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2917,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2917,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2918,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2919,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2920,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2921,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2922,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2922,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2923,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2924,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2925,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2926,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2926,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2926,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2927,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2927,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2927,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2928,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2929,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2929,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2929,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2930,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2930,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2930,3,Salivary hypersecretion,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2930,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2931,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2931,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2931,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2932,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2933,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2933,2,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2933,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2933,4,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2933,5,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2934,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2935,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2935,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2936,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2936,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2937,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2937,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2938,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2939,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2940,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2941,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2942,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
2943,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2943,2,Migraine,Migraine headaches,Headaches,Nerv,N
2944,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2944,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2945,1,Nasal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2945,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2946,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2947,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2947,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2947,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2948,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2949,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2949,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2949,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2950,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2951,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2952,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2953,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2954,1,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2955,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2956,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2957,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2957,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2957,3,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
2957,4,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2958,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2959,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2959,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2959,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2960,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2961,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2962,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2962,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2963,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2963,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2964,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2964,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2965,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
2966,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2966,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2967,1,Headache,Headaches NEC,Headaches,Nerv,N
2968,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2968,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2969,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2970,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2970,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2970,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2970,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2971,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2972,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2973,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2973,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2973,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2973,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2973,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2973,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2973,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2973,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2974,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2974,2,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
2975,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2976,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2977,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2977,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2977,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2978,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2978,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2979,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2980,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2980,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2981,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2981,2,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2981,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2982,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2982,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2983,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2983,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2983,3,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2984,1,Application site dryness,Application site reactions,Administration site reactions,Genrl,N
2985,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2986,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
2987,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2988,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2989,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2990,1,Headache,Headaches NEC,Headaches,Nerv,N
2990,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2990,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2990,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2991,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2992,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2992,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2992,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2993,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
2993,2,Application site rash,Application site reactions,Administration site reactions,Genrl,N
2994,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2995,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2996,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2996,2,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2997,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
2997,2,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2998,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2999,1,Headache,Headaches NEC,Headaches,Nerv,N
2999,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2999,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
3000,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3001,1,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
3001,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3002,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
3002,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3003,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3004,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
3004,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3005,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
3006,1,Application site laceration,Application site reactions,Administration site reactions,Genrl,N
3006,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3006,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3007,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3007,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3007,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3007,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
3007,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3008,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3008,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
3008,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3008,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3009,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3009,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3009,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
3009,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3009,5,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3010,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3010,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3010,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
3010,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3010,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3011,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
3012,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3013,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3013,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3014,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
3015,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3015,2,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
3015,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
3015,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3016,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
3016,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
3016,3,Headache,Headaches NEC,Headaches,Nerv,N
3016,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3016,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3016,6,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3016,7,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3017,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3018,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3019,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3019,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
3019,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3020,1,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3021,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3021,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3022,1,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3022,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3023,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3024,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
3024,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3024,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
3024,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
3025,1,Application site burn,Application site reactions,Administration site reactions,Genrl,N
3025,2,Application site discolouration,Application site reactions,Administration site reactions,Genrl,N
3025,3,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3026,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3026,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
3027,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3028,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3029,1,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3029,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
3030,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
3031,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3031,2,Application site hypersensitivity,Application site reactions,Administration site reactions,Genrl,N
3031,3,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3032,1,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3033,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3034,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3034,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3034,3,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
3034,4,Product adhesion issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3035,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
3035,2,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
3035,3,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
3035,4,Application site rash,Application site reactions,Administration site reactions,Genrl,N
3036,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
3037,1,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
3038,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3038,2,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
3039,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
3040,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3040,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
3040,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3041,1,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
3041,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3042,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
3043,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3043,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
3044,1,Nicotine dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
3044,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
